Assessing the mechanisms of brain plasticity by transcranial magnetic stimulation

A Jannati, LM Oberman, A Rotenberg… - …, 2023 - nature.com
Transcranial magnetic stimulation (TMS) is a non-invasive technique for focal brain
stimulation based on electromagnetic induction where a fluctuating magnetic field induces a …

[HTML][HTML] Clinical diagnostic utility of transcranial magnetic stimulation in neurological disorders. Updated report of an IFCN committee

S Vucic, KHS Chen, MC Kiernan, M Hallett… - Clinical …, 2023 - Elsevier
The review provides a comprehensive update (previous report: Chen R, Cros D, Curra A, Di
Lazzaro V, Lefaucheur JP, Magistris MR, et al. The clinical diagnostic utility of transcranial …

Diagnostic contribution and therapeutic perspectives of transcranial magnetic stimulation in dementia

V Di Lazzaro, R Bella, A Benussi, M Bologna… - Clinical …, 2021 - Elsevier
Transcranial magnetic stimulation (TMS) is a powerful tool to probe in vivo brain circuits, as it
allows to assess several cortical properties such as excitability, plasticity and connectivity in …

[HTML][HTML] Cortical plasticity is correlated with cognitive improvement in Alzheimer's disease patients after rTMS treatment

X Li, G Qi, C Yu, G Lian, H Zheng, S Wu, TF Yuan… - Brain stimulation, 2021 - Elsevier
Objective Repetitive transcranial magnetic stimulation (rTMS) has been widely used in non-
invasive treatments for different neurological disorders. Few biomarkers are available for …

Decreased frontal gamma activity in Alzheimer disease patients

EP Casula, MC Pellicciari, S Bonnì, I Borghi… - Annals of …, 2022 - Wiley Online Library
Objective In Alzheimer disease (AD) animal models, synaptic dysfunction has recently been
linked to a disorder of high‐frequency neuronal activity. In patients, a clear relation between …

Toward noninvasive brain stimulation 2.0 in Alzheimer's disease

A Menardi, S Rossi, G Koch, H Hampel… - Ageing research …, 2022 - Elsevier
Noninvasive brain stimulation techniques (NiBS) have gathered substantial interest in the
study of dementia, considered their possible role in help defining diagnostic biomarkers of …

Neurophysiological biomarkers using transcranial magnetic stimulation in Alzheimer's disease and mild cognitive impairment: A systematic review and meta-analysis

Y Mimura, H Nishida, S Nakajima, S Tsugawa… - Neuroscience & …, 2021 - Elsevier
Transcranial magnetic stimulation (TMS) is a non-invasive neurophysiological tool that
enables the investigation of cortical excitability in the human brain. Paired-pulse TMS …

Past, present, and future of non-invasive brain stimulation approaches to treat cognitive impairment in neurodegenerative diseases: time for a comprehensive critical …

C Sanches, C Stengel, J Godard, J Mertz… - Frontiers in Aging …, 2021 - frontiersin.org
Low birth rates and increasing life expectancy experienced by developed societies have
placed an unprecedented pressure on governments and the health system to deal …

Neurophysiological markers of Alzheimer's disease: quantitative EEG approach

U Smailovic, V Jelic - Neurology and therapy, 2019 - Springer
Currently established and employed biomarkers of Alzheimer's disease (AD) predominantly
mirror AD-associated molecular and structural brain changes. While they are necessary for …

Serum glial fibrillary acidic protein (GFAP) is a marker of disease severity in frontotemporal lobar degeneration

A Benussi, NJ Ashton, TK Karikari… - Journal of …, 2020 - content.iospress.com
Background: It is still unknown if serum glial fibrillary acidic protein (GFAP) is a useful marker
in frontotemporal lobar degeneration (FTLD). Objective: To assess the diagnostic and …